Skip to content
    Drishti.money
    Earnings calls

    IOL Chemicals concall ledger

    Every earnings call for IOLCP — management tone, guidance, KPIs and promise tracking, quarter by quarter.

    IOLCP · 6 transcripts · Healthcare · latest Q4 FY26
    Q4 FY26Published 28 May 2026Call held 28 May 2026

    IOLCP Q4 FY26 Earnings Call Transcript & Analysis

    Revenue₹619 cr+17% YoYEBITDA₹94 cr+38% YoYEBITDA Margin15.2%PAT₹53 cr+66% YoYPAT Margin8.6%

    Revenue (Q4 FY26) ₹619 cr (+17% YoY); EBITDA (Q4 FY26) ₹94 cr (+38% YoY); EBITDA Margin (Q4 FY26) 15.2%. Revenue from operations grew 17.4% YoY to INR619 crores in Q4 FY26.

    Read full transcript & analysis
    Q3 FY26Published 12 Feb 2026Call held 12 Feb 2026

    IOLCP Q3 FY26 Earnings Call Transcript & Analysis

    Revenue from Operations₹580 cr+11% YoYEBITDA₹62.6 cr+23% YoYEBITDA Margin10.7%

    Revenue from Operations (Q3 FY26) ₹580 cr (+11% YoY); EBITDA (Q3 FY26) ₹63 cr (+23% YoY); EBITDA Margin (Q3 FY26) 10.7%. Q3 FY26 Revenue from operations grew 10.9% YoY to INR 580 crores.

    Read full transcript & analysis
    Q4 FY25Published 20 May 2025Call held 20 May 2025

    IOLCP Q4 FY25 Earnings Call Transcript & Analysis

    Revenue₹528 cr+5% YoYEBITDA₹67 cr+17% YoYEBITDA Margin12.7%PAT₹31.6 cr+12% YoYPAT Margin5.9%

    Revenue (Q4 FY25) ₹528 cr (+5% YoY); EBITDA (Q4 FY25) ₹67 cr (+17% YoY); EBITDA Margin (Q4 FY25) 12.7%. Q4 FY25 Revenue from operations grew to INR528 crores, marking a 4.7% YoY growth.

    Read full transcript & analysis